Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS
Phase 1
Terminated
- Conditions
- Multiple Sclerosis, Relapsing-Remitting
- First Posted Date
- 2015-04-16
- Last Posted Date
- 2015-11-04
- Lead Sponsor
- Genesis Limited
- Target Recruit Count
- 69
- Registration Number
- NCT02418325
- Locations
- 🇹🇹
Genesis Institute of Cellular Medicine, Genesis (Trinidad and Tobago) Private Limited, San Fernando, Trinidad, Trinidad and Tobago
News
No news found